Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. - Wikidata - awgldk - TriplyDB

Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease.

Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease.

http://www.wikidata.org/entity/Q39411963

about

Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons Disease What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?Tool compounds robustly increase turnover of an artificial substrate by glucocerebrosidase in human brain lysates Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system.Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions Are there roles for brain cell senescence in aging and neurodegenerative disorders?Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.The Interplay between Alpha-Synuclein Clearance and Spreading Cathepsin E Deficiency Ameliorates Graft-versus-Host Disease and Modifies Dendritic Cell Motility.Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment.Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.Biomarker Research in Parkinson's Disease Using Metabolite Profiling.Alpha galactosidase A activity in Parkinson's disease.Network and Pathway-Based Analyses of Genes Associated with Parkinson's Disease.The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients.Ageing, Cellular Senescence and Neurodegenerative Disease

P2860

Q26776209-CA597B85-00A6-43A6-9F8C-A101BF1B8F96 Q28083203-AEFBC97D-24E0-407C-A6AE-F2ED8B860A88 Q28543988-6770B927-DE4E-4D1A-8A65-02AAB6F72133 Q33768132-79893091-418D-4D6D-B1D0-0DF2BC59BEAD Q33831118-EEF74E0A-5700-408E-A563-84CE2C5ED1CB Q34237637-3BAEDA09-21D2-44C2-AC9B-B276F328BAD1 Q34688159-4F4A4CEB-DE99-4EA7-B126-8F20292A52DC Q34714560-089F5956-051E-4D2D-A784-B2AC386474AD Q34806122-620A13EE-A080-4D38-B946-C3EF1C2F5ECE Q35596071-E1512070-AE14-40E2-B5B2-AF7759EFF16D Q35833984-1F2BC495-EAF3-4EDA-9ABB-88BD2EA137EB Q37672390-40A414DE-1547-45C4-8C67-411E67EED73A Q38271572-30274DBB-C593-4CBB-9E3B-234045519469 Q38765856-0E5930DC-2BDC-4338-A934-18F7071CB20E Q38811401-8304980C-4970-40E7-BB61-8C71A8489259 Q38825497-6FF8A959-49B4-4D23-BFF6-1D20C03BF647 Q41666702-362335F7-9B4E-4426-A765-3A74EC89DBA0 Q47840041-7199CE72-6BC0-42B9-9BB7-E33F0870ABC2 Q48184416-55631036-B1B6-4286-A8EB-EF7890E6C5A8 Q55357756-2C860D46-D6BA-4E80-BFC2-8427DFCBC090 Q59133878-F2683A1E-4697-4489-BF6E-3C226B6A85A3

P2860

Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease.

http://www.wikidata.org/entity/Q39411963

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Changes in endolysosomal enzym ...... ents with Parkinson's disease.

@en

Changes in endolysosomal enzym ...... ents with Parkinson's disease.

@nl

type

label

Changes in endolysosomal enzym ...... ents with Parkinson's disease.

@en

Changes in endolysosomal enzym ...... ents with Parkinson's disease.

@nl

prefLabel

Changes in endolysosomal enzym ...... ents with Parkinson's disease.

@en

Changes in endolysosomal enzym ...... ents with Parkinson's disease.

@nl

P1433

Q39411963-6A3497E1-F46F-4DC1-A11E-FE1DA9DAC539

P1476

Q39411963-AC6A901B-3894-4466-90FA-5A022FBD5CE1

P2093

Q39411963-1FAA3330-F9D0-4BEF-BF16-E4A650AA1165

Q39411963-397F7518-AED0-4D87-A574-1325FA60C5A7

Q39411963-483FB938-4FED-43C7-B549-75A23C7255B2

Q39411963-5DCD426A-6F45-43AC-A46E-B9B36E31B048

Q39411963-92168103-7B31-4E40-A9AC-A7A90CF04CE2

Q39411963-B92B492D-FBF7-443F-9B6A-78FF708F4309

Q39411963-C9307327-0F9B-47B7-B8F5-7FF309CD40DC

Q39411963-CA08653A-BA38-4BCD-885E-605661E5ECFE

P2860

Q39411963-0B52CB1D-7D89-4D22-BEA8-3F1BD870A286

Q39411963-0B63F846-BA88-4023-88D7-4A237D493D56

Q39411963-0D5F1198-88C9-4D36-B800-DD852B176233

Q39411963-177AE3FB-7AFD-4A78-9CD8-C12170286C4C

Q39411963-17AEFE4B-02C4-49E8-A166-44AFE142E0D6

Q39411963-1BB41614-7C76-4DA6-9168-BE46489649CF

Q39411963-1F1E17B8-FDD6-42A1-9E30-B6449C27F20A

Q39411963-21D6C13C-881E-4E5E-9897-384A1A57CF7D

Q39411963-2629DC28-C0B0-420F-A6C1-010B5CFE7CFD

Q39411963-286A2B2A-CA95-4FC5-81D7-3A0F682AFC7F

P304

Q39411963-F8C387E7-29D3-42D3-9B46-D8576A00776A

P31

Q39411963-71A16CD5-3879-492B-9CB7-7F94FC10409C

P356

Q39411963-733210E1-40E7-425C-B682-C7D3F2858640

P407

Q39411963-30634E35-BCA0-4EBD-88F1-E895109E5293

P433

Q39411963-183B8675-3135-4D8E-8F84-4510586FBA6F

P478

Q39411963-3A219DC3-B617-4AFC-89B1-48508A64CEFF

P50

Q39411963-65DE896B-1EB6-46D3-A425-120CD615001C

P577

Q39411963-C9989524-1224-40C2-B6EB-00CF13C35E09

P698

Q39411963-D2AEFFBA-3432-4AFF-90F6-A43618D00843

P921

Q39411963-A5FD6561-DCD0-491E-858F-2EC493EFAAF8

Q39411963-AE4A0AE2-2A4D-49F5-8757-F80499FCFF43

P356

P1433

Movement Disorders

P1476

Changes in endolysosomal enzym ...... ents with Parkinson's disease.

@en

P2093

Davide Chiasserini

http://www.w3.org/2001/XMLSchema#string

Emanuele Persichetti

http://www.w3.org/2001/XMLSchema#string

Karin D van Dijk

http://www.w3.org/2001/XMLSchema#string

Lucilla Parnetti

http://www.w3.org/2001/XMLSchema#string

Paolo Calabresi

http://www.w3.org/2001/XMLSchema#string

Paolo Eusebi

http://www.w3.org/2001/XMLSchema#string

Tommaso Beccari

http://www.w3.org/2001/XMLSchema#string

Wilma D J van de Berg

http://www.w3.org/2001/XMLSchema#string

P2860

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

Glucocerebrosidase mutations in subjects with parkinsonism

Parkinsonism: onset, progression and mortality

Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS)

The expression and function of cathepsin E in dendritic cells

Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E

Autophagy as a regulated pathway of cellular degradation

Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy

P304

747-754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.25495

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Henk W. Berendse

P577

2013-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23712522

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

cerebrospinal fluid